SanaRx Biotherapeutics
Medford, US · Founded 2018 · Delaware corporation
Founders & leadership
CN
Carl NovinaNamed on SEC filing
FP
Frederick PierceNamed on SEC filing
FM
Fred MermelsteinNamed on SEC filing
JN
Julia NovinaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$355K disclosed across 1 round · 2019
▶$355KraisedOct 2019 · 8 investors · BiotechnologyRule 506(b)
▶$355KraisedOct 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl NovinaDirector, Promoter
- Frederick PierceExecutive Officer, Director, Promoter
- Fred MermelsteinDirector, Promoter
- Julia NovinaExecutive Officer, Director, Promoter
- Offering amount
- $1.2M
- Amount sold
- $355K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 04, 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has SanaRx Biotherapeutics raised?
- SanaRx Biotherapeutics has disclosed $355K raised across 1 round.
- Where is SanaRx Biotherapeutics headquartered?
- SanaRx Biotherapeutics is headquartered in Medford, US.